cefixime has been researched along with Hemorrhagic Fever, Ebola in 1 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
Hemorrhagic Fever, Ebola: A highly fatal, acute hemorrhagic fever caused by EBOLAVIRUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aluisio, AR | 1 |
| Perera, SM | 1 |
| Yam, D | 1 |
| Garbern, S | 1 |
| Peters, JL | 1 |
| Abel, L | 1 |
| Cho, DK | 1 |
| Woldemichael, D | 1 |
| Kennedy, SB | 1 |
| Massaquoi, M | 1 |
| Sahr, F | 1 |
| Liu, T | 1 |
| Levine, AC | 1 |
1 other study available for cefixime and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
Association between treatment with oral third-generation cephalosporin antibiotics and mortality outcomes in Ebola virus disease: a multinational retrospective cohort study.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Cefixime; Cohort Studies; Disease Outbreaks; Fem | 2020 |